Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain
- 28 February 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8692), 747-750
- https://doi.org/10.1016/0140-6736(90)90868-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- DISTURBANCE OF CEREBRAL FUNCTION BY ALUMINIUM IN HAEMODIALYSIS PATIENTS WITHOUT OVERT ALUMINIUM TOXICITYThe Lancet, 1989
- GEOGRAPHICAL RELATION BETWEEN ALZHEIMERS-DISEASE AND ALUMINUM IN DRINKING-WATER1989
- Residual renal function in hemodialysis patients may protect against hyperaluminemiaKidney International, 1987
- Serum Aluminum Levels and Erythrocyte Dihydropteridine Reductase Activity in Patients on HemodialysisNew England Journal of Medicine, 1987
- Transferrin binding of Al3+ and Fe3+.Clinical Chemistry, 1987
- Dietary citric acid enhances absorption of aluminum in antacids.Clinical Chemistry, 1986
- Presenile dementia—the use of the flash and pattern vep in diagnosisElectroencephalography and Clinical Neurophysiology, 1984
- Plasma aluminum is bound to transferrinLife Sciences, 1983
- Identification of a new serum protein polymorphism as transferrinHuman Genetics, 1978
- Pulmonary Fibrosis and Encephalopathy Associated with the Inhalation of Aluminium DustOccupational and Environmental Medicine, 1962